Publicacions
-
Turkova A, White E, Kekitiinwa AR, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe GM, Moloantoa T, Srirompotong U, Mosia NR, Puthanakit T, Kobbe R, Fortuny-Guasch C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi MF, Klein N, Mujuru HA, Kityo C, Cotton MF, Ferrand RA, Giaquinto C, Rojo P, Violari A, Gibb DM and Ford D.
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
LANCET CHILD & ADOLESCENT HEALTH . 7(10): 718-727. Nº de cites: 4
-
Baquero-Artigao, F, del Rosal, T, Falcón-Neyra, L, Ferreras-Antolín, L, Gómez-Pastrana, D, Hernanz-Lobo, A, Méndez-Echevarría, A, Noguera-Julian A, Sánchez, MTP, Rodríguez-Molino, P, Piñeiro-Pérez, R, Santiago-García, B and Soriano-Arandes, A.
Update on the diagnosis and treatment of tuberculosis
ANALES DE PEDIATRIA . 98(6): 460-469. Nº de cites: 12
-
Buonsenso D, Noguera-Julian A, Moroni R, Hernández-Bartolomé A, Fritschi N, Lancella L, Cursi L, Soler-García a, Krüger R, Feiterna-Sperling C, Sali M, Lo Vecchio A, Scarano S, Hernanz Lobo A, Espiau M, Soriano-Arandes A, Cetin BS, Brinkmann F, Ozere I, Baquero-Artigao F, Tsolia M, Milheiro Silva T, Bustillo-Alonso M, Martín Nalda A, Mancini M, Starshinova A, Ritz N, Velizarova S, Ferreras-Antolín L, Götzinger F, Bilogortseva O, Chechenyeva V, Tebruegge M and Santiago-García B.
Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study
Thorax . 78(3): 288-296. Nº de cites: 19
-
López-Ramos MG, Vinent-Genestar J, Aarnoutse R, Colbers A, Velasco E, Martorell-Sampol L, Falcón-Neyra L, Neth O, Prieto L, Guillén S, Baquero-Artigao F, Méndez-Echevarría A, Gómez-Pastrana D, Jiménez AB, Lahoz R, Ramos-Amador JT, Soriano-Arandes A, Santiago B, Rosa Farré Riba, Fortuny-Guasch C, Soy D and Noguera-Julian A.
Adequacy of the 10 mg/kg Daily Dose of Antituberculosis Drug Isoniazid in Infants under 6 Months of Age
ANTIBIOTICS-BASEL . 12(2): .
-
Calzada-Hernández J, Anton-Lopez J, Martín-de-Carpi J, López-Montesinos B, Calvo I, Donat E, Núñez E, Blasco Alonso J, Mellado MJ, Baquero-Artigao F, Leis R, Vegas-Álvarez AM, Medrano San Ildefonso M, Pinedo-Gago MDC, Eizaguirre FJ, Tagarro A, Camacho-Lovillo M, Pérez-Gorricho B, Gavilán-Martín C, Guillén S, Sevilla-Pérez B, Peña-Quintana L, Mesa-Del-Castillo P, Fortuny-Guasch C, Tebruegge M and Noguera-Julian A.
Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-a inhibitor initiation in children in Spain
EUROPEAN JOURNAL OF PEDIATRICS . 182(1): 307-317. Nº de cites: 12
-
Polo R, García-Albéniz X, Terán C, Morales M, Rial-Crestelo D, Garcinuño MA, García Del Toro M, Hita C, Gómez-Sirvent JL, Buzón L, Díaz de Santiago A, Pérez Arellano JL, Sanz J, Bachiller P, Martínez Alfaro E, Diaz de Brito V, Masiá M, Hernández-Torres A, Guerra J, Santos J, Arazo P, Muñoz L, Arribas JR, Martínez de Salazar P, Moreno S, Hernán MA, Del Amo J, Del Amo J, Rosa Polo, Moreno S, Berenguer J, Martínez E, Hernán M, Martínez de Salazar P and García de Albéniz X.
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers
CLINICAL MICROBIOLOGY AND INFECTION . 29(1): 85-93. Nº de cites: 10
-
Soler-García a, Gamell A, Pérez-Porcuna T, Soriano-Arandes A, Begoña Santiago García, Tórtola T, Ruiz-Serrano MJ, Korta Murua JJ, Bustillo-Alonso M, Garrote-Llanos MI, Rodríguez-Molino P, Piqueras AI, Tagarro A, Manuel Monsonis Cabedo, Tebruegge M, Noguera-Julian A and QFT-Plus Study Group of the Spanish Pediatric TB Research Network.
Performance of QuantiFERON-TB Gold Plus assays in children and adolescents at risk of tuberculosis: a cross-sectional multicentre study
Thorax . 77(12): 1193-1201. Nº de cites: 13
-
Velasco E, Batllori-Tragant M, Manuel Monsonis Cabedo, Valls-Lafon A, Rios-Barnés M, Simó-Nebot S, Gamell Fullà A, Fortuny-Guasch C, Tebruegge M and Noguera-Julian A.
Host, technical, and environmental factors affecting QuantiFERON-TB Gold In-Tube performance in children below 5 years of age
SCIENTIFIC REPORTS . 12(1): 19908-19908. Nº de cites: 3
-
Aguilera-Alonso, D, Solis-Garcia, G, Noguera-Julian A, Gonzalez-Martin, J, Cobena, AR, Baquero-Artigao, F, Rueda, CT, Rodriguez-Molino, P, Sanchez, IB, Vallmanya, T, Bernet-Sanchez, A, Domingo, LM, Rubio, A, Saavedra-Lozano, J, Ruiz-Serrano, MJ, Blazquez-Gamero, D, Lopez-Roa, P, Gomez-Pastrana, D, Prieto, MDL, Medina, EML, Gil-Brusola, A, Nalda, AM, Soriano-Arandes, A, Tortola, T, Falcon-Neyra, L, Galan, VG, Tebruegge, M and Santiago-Garcia, B.
Accuracy of Xpert Ultra for the diagnosis of paediatric tuberculosis in a low TB burden country: a prospective multicentre study
Thorax . 77(10): 1023-1029. Nº de cites: 9
-
Torres-Fernandez D, Jiménez de Ory S, Fortuny-Guasch C, Sainz T, Falcón D, Bernal E, Jiménez MC, Vilasaró MN, Epalza C, Navarro M, Ramos JT, Holguín Á and Prieto L.
Integrase inhibitors in children and adolescents: clinical use and resistance
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 77(10): 2784-2792. Nº de cites: 4